GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Insider Ownership

Vilacto Bio (Vilacto Bio) Insider Ownership : 5.56 % (As of Jun. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vilacto Bio's insider ownership is 5.56%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vilacto Bio's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vilacto Bio's Float Percentage Of Total Shares Outstanding is 95.30%.


Vilacto Bio Insider Ownership Historical Data

The historical data trend for Vilacto Bio's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Insider Ownership Chart

Vilacto Bio Historical Data

The historical data trend for Vilacto Bio can be seen below:

2018-02-28 2018-03-31 2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2018-10-31 2018-11-30
Insider Ownership 5.56 5.56 5.56 5.56 5.56 5.56 5.56 5.56 5.56 5.56

Vilacto Bio Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Vilacto Bio (Vilacto Bio) Business Description

Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.